Gene Kinney is the current President and Chief Executive Officer of Prothena, a biopharmaceutical company specializing in dysregulated proteins.
Gene Kinney is the current President and Chief Executive Officer of Prothena, a biopharmaceutical company specializing in dysregulated proteins and neurodegenerative diseases. He has been with Prothena since its spin-out from Lanx Pharmaceuticals in 2012, where he has been instrumental in the company's clinical and strategic development. Kinney has represented Prothena at significant industry events, discussing the company's focuses on Alzheimer's and Parkinson's disease.
Full founder directory · Investor directory · Company funding database · Fundraising library